Author:
Tappenden P.,Jones R.,Paisley S.,Carroll C.
Reference21 articles.
1. Cancer Research UK: cancer facts. Available from [accessed 30/04/2007].
2. National Institute for Health and Clinical Excellence. Technology assessment guidance TA93: Irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer. London, NICE; 2005.
3. Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer;Tappenden;Health Technol Assess,2007
4. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;New Engl J Med,2004
5. Addition of bevacizumab to bolus flourouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial;Kabbinavar;J Clin Oncol,2005
Cited by
69 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献